Oula,Biohm,Nest Genomics
Alira Health Raises Additional $58M in Funding
Alira Health, a Framingham, MA-based healthcare advisory, clinical research and technology company, raised additional $58M in funding.
The backers were not disclosed.
The company intends to use the funds to accelerate the delivery of patient-centric, technology-enabled healthcare solutions.
Led by CEO Gabriele Brambilla and CCO Benjamin Chambon, Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.
Alira Health Raises Additional $58M in Funding
Alira Health, a Framingham, MA-based healthcare advisory, clinical research and technology company, raised additional $58M in funding
Healthcare fintech Paytient raises $40.5M
Missouri-based healthcare fintech Paytient announced it had secured $40.5 million in Series B funding, bringing the company's total raise to $63 million. The funds include $33 million in equity from new and existing investors and $7.5 million in debt from Silicon Valley Bank.
Mercato Partners Traverse Fund led the round, with participation from Bertelsmann Investments. Mercato's managing director, Joe Kaiser, is joining Paytient's board of directors, and Bertelsmann's Thorsten Wirkes is entering as an observer.
Existing investors included Left Lane Capital, Commerce Bank, Box Group, Felicis Ventures, Lightbank, Lachy Groom, Crossbeam Ventures, Inspired Capital and Cultivation Capital.
The funding will help the health payment accounts company increase growth and product development in 2023.
Paytient partners with employers, insurers and health systems to offer employees and members an interest-free line of credit. Using a Paytient Visa card, the employee or member can pay their healthcare provider in full, then repay Paytient according to a payment plan chosen on the payment assistance provider's app.
The platform gives patients the power to control when and how they pay medical expenses in a way that's good for their own wellbeing, and as historic inflation grips the market, this is solving an urgent need for employers and providers, too.
Healthcare fintech Paytient raises $40.5M | MobiHealthNews
The investment, a mix of equity and debt, will go toward company growth and product development.
Array Behavioral Care announces $25M funding round led by CVS Health
New Jersey-based virtual psychiatry and therapy platform Array Behavioral Care scored $25 million in its latest funding round led by CVS Health. Additional capital was provided by existing investors.
CVS Health joins Array's earlier investors in supporting the company, including Wells Fargo Strategic Capital, Harbour Point Capital, Health Velocity Capital, OSF Healthcare, HLM Venture Partners and OCA Ventures.
The funding will help Array scale its virtual behavioral therapy platform, which the company says CVS Health will allow it to do faster.
Dr. David Fairchild, senior vice president and chief medical officer of retail health at CVS Health, will also join Array's board of directors.
Array Behavioral Care announces $25M funding round led by CVS Health | MobiHealthNews
The investment will help expand the telepsychiatry platform’s reach.
Oula Rakes in $19.1M for Hybrid Maternity Clinic
Hybrid maternity clinic Oula announced Thursday that it secured $19.1 million in Series A funding, which will allow the company to boost its full-service pregnancy care.
The funding round was led by 8VC and included participation from Chelsea Clinton’s fund, Metrodora; the Female Founders Fund; Collaborative Fund; and Alumni Ventures. In total, Oula has raised $22.3 million.
8VC chose to invest in Oula because of the extreme growth it’s experienced since opening in 2021, signaling the need for maternity care, said Kimmy Scotti, 8VC founding partner. Three months after opening its location, the company reached full capacity, leading Oula to open its second and doubling its employee base.
New York City-based Oula was founded by Adrianne Nickerson and Elaine Purcell in 2021 while they were both pregnant. The company provides midwifery and obstetrics services, whether it’s for prenatal care, delivery or postpartum care. It also offers pregnancy and birth education, virtual coaching, community events and an app for support between appointments. Oula has two clinics located in New York City and is in network with most major insurance providers, including UnitedHealthcare, Blue Cross Blue Shield and Aetna.
Oula Rakes in $19.1M for Hybrid Maternity Clinic - MedCity News
The funding round was led by 8VC and included participation from Chelsea Clinton’s fund, Metrodora; the Female Founders Fund; Collaborative Fund; and Alumni Ventures. In total, Oula has raised $22.3 million. The company plans to use the funds to grow in its New York market and add more services.
ModifyHealth Raises $10M in Series B Funding
ModifyHealth, an Atlanta, GA-based provider of a nationwide food as medicine platform and provider of medically tailored meals, raised $10M in Series B funding.
The round was led by RC Capital (RCC) with participation from existing investor Nashville Capital Network.
The company intends to use the funds to support its continued growth of its category food as medicine solutions and further expansion of its nationwide operations to deliver meaningful patient outcomes.
Led by GB Pratt, Founder & CEO, ModifyHealth is a food as medicine platform and provider of medically tailored meals. Working directly with patients and partnering with payors, employers, and healthcare systems, its program decreases cost and improves outcomes for chronic conditions like type 2 diabetes, hypertension, kidney disease, obesity, and irritable bowel syndrome, where dietary management is a recommended treatment.
ModifyHealth Raises $10M in Series B Funding
ModifyHealth, an Atlanta, GA-based provider of a nationwide food as medicine platform and provider of medically tailored meals, raised $10M in Series B funding
Censinet Raises $9M in Funding
Censinet, a Boston, MA-based provider of healthcare risk management solutions, raised $9M in funding.
The round was led by MemorialCare Innovation Fund, Rex Health Ventures and Ballad Ventures, with participation from LRVHealth, HLM Venture Partners, Schooner Capital, Excelerate Health Ventures, and Cedars Sinai.
The company intends to use the funds to accelerate growth and expand operations.
Led by CEO Ed Gaudet, Censinet provides Censinet RiskOps, a cloud-based risk exchange of healthcare organizations working together to manage and mitigate cyber risk. Purpose-built for healthcare, Censinet RiskOps delivers total automation across all third party and enterprise risk management workflows and best practices. With a Digital Risk CatalogTM of over 34,000 vendors and products, automated corrective action plans, real-time portfolio management, and Board-ready reporting with actionable insights, customers manage and mitigate third-party risk across the entire vendor and product lifecycle.
Censinet Raises $9M in Funding
Censinet, a Boston, MA-based provider of healthcare risk management solutions, raised $9M in funding
Nest Genomics Raises $8.5M to Increase Access to Patients’ Genetic Information
Nest Genomics closed an $8.5 million seed financing round on Tuesday.
The round was led by B Capital. Several other investors participated, including Y Combinator, Samsung Next, Maven Ventures and 23andMe CEO Anne Wojcicki.
Nest, founded last year, is based in New York and has offices in San Francisco and Tel Aviv. The startup’s founders, Moran Snir and her husband Guy, have built a genomics company before. Their previous company, called Clear Genetics, was acquired by Invitae in 2019.
The company provides the software infrastructure needed for health systems, clinics, pharmaceutical companies and payers to launch and scale genomic programs. Nest’s platform has several electronic health record-integrated tools for providers, such as tools for patient triage, test ordering and clinical decision support for managing patients’ genetic results based on the latest clinical guidelines.
Patients also need easy and secure access to their genetic information, Snir declared. Nest’s platform includes several features for patients, including personalized educational content, results sharing and reminders for screening.
Nest Genomics Raises $8.5M to Increase Access to Patients’ Genetic Information - MedCity News
Nest Genomics just closed a $8.5 million seed financing round. The company provides the software infrastructure needed for health systems, clinics, drugmakers and payers to launch and scale genomic programs. It also provides tools for patients to easily access their genetic information.
Biohm Raises $7.5M in Equity Financing
Biohm, a Cleveland, OH-based microbiome company, raised $7.5M in equity financing.
The round was led by VTC Ventures, with participation from Felton Group, LLC, Jobs Ohio Growth Capital Fund, Aztec Capital Management LLC, Cleveland Life Science Advisors, Valley Growth Ventures, LLC, and Jump Start, Inc.
The company intends to use the funds to fast-track growth of A.I. technology and targeted, data-driven microbiome formulations.
Led by CEO Afif Ghannoum, and President Sam Schatz, Biohm uses microbiome data to create new products and ingredients to help individuals live healthier lives. Its first BIOHM FX probiotic supplement was designed to specifically help reduce digestive plaque found in the gut. The company has expanded its line of microbiome data-powered products to include more probiotic and prebiotic supplements, as well as a personalized Gut Test.
Biohm Raises $7.5M in Equity Financing
BIOHM, a Cleveland, OH-based microbiome company, raised $7.5M in equity financing
Ferrum Health Raises $6M in Funding
Ferrum Health, a San Francisco, CA-based healthcare artificial intelligence (AI) platform developer, raised $6M in funding.
The round was led by Urban Innovation Fund, Cercano Management, and Singtel Innov8.
The company intends to use the funds to continue developing its Enterprise AI Platform, designed to help healthcare providers improve patient care, and to expand its health system customer base to make intelligent healthcare accessible to all.
Le day CEO Pelu Tran, Ferrum Health developed an Enterprise AI deployment platform to improve patient outcomes. The solution provides AI Hubs able to run countless applications across many service lines and integrate clinical imaging and administrative data. The AI platform uses advanced machine learning algorithms to analyze medical data, providing doctors with insights and recommendations that can help improve patient care. Ferrum has already seen significant traction for its system, with major healthcare organizations such as Sutter Health and Carle Clinic adopting its technology. As of 2022, more than 750,000 patient records have been analyzed via the Ferrum Enterprise AI Platform.
Ferrum Health Raises $6M in Funding
Ferrum Health, a San Francisco, CA-based healthcare artificial intelligence (AI) platform developer, raised $6M in funding
Cari Health Raises $2.3M in Seed Funding
Cari Health, a San Diego, CA-based digital health startup, raised $2.3M in Seed funding.
The round was led by San Diego Angel Conference (SDAC), with participation from NuFund Venture Group, Cove Fund, Chemical Angel Fund, and Medical Devices of Tomorrow, and several individual angel investors.
The company intends to use the funds to expand its intellectual property portfolio, and prepare for the regulatory pathway with the Food and Drug Administration.
Led by Founder and CEO Patrik Schmidle, Cari Health is focused on wearable remote medication monitoring, enabling clinicians to view medication levels in real-time, customize dosages for patients, and keep them on life-saving medications. While the solution can detect a number of medications, the first application will be to enable patients being treated with medications for opioid use disorder (MOUD) to prove treatment compliance remotely, without frequent clinic visits.
The company participated in programs like the Qualcomm Institute Innovation Space, Institute for the Global Entrepreneur MedTech Accelerator program at University of California San Diego, and MedTech Innovator program.
